1: TOR Amendment Details - Environmental Clearance

70

Transcript of 1: TOR Amendment Details - Environmental Clearance

Table -1: TOR Amendment Details

S. N.

In TOR Application TOR Amendment Required Justification

1 Company Name: Richmond Pharmaceuticals & Research LLP Company Name: Richmond Research & Pharmaceuticals LLP As per the land document, company’s name is Richmond Research & Pharmaceuticals LLP. Copy of this document is attached as

Annexure-1.

2 Flue Gas Stack details:

S. No.

Stack Attached

to Fuel Consumption

Stack Height

(m)

Type of Emissions i.e. Air Pollutants

Air Pollution Control Measures (APCM)

1 IBR Boiler Diesel 100 kg/Day 11.0 PM, SO2, NOX Adequate Stack Height

Flue gas stack Details:

S. No.

Stack Attached

to Fuel Consumption

Stack Height

(m)

Type of Emissions

i.e. Air Pollutants

Air Pollution Control Measures (APCM)

1

IBR Boiler

(500 kg/hr)

Bio Coal (Briquettes)

OR

Imported Coal

1.2 MT/Day

OR

2 MT/Day

11.0 PM, SO2, NOX Multi Cyclone Dust collector

2 DG Set

(100 kVA) Diesel 60 ltr/hr 7.5 PM, SO2, NOX Adequate Stack Height

Benefits for using Bio-Coal (Briquettes):

This converts bio waste to Energy. So, it is environment friendly fuel.

Clean burning – minimal smoke, creosote and ash. Briquettes do not emit smoke with sulfur or phosphorus and also fly ash, hence no need of pollution control equipment.

Benefit for Using Imported coal:

Imported coal is more economical. Unit will provide close shed with boundary wall, multi cyclone

dust collector to control air emissions to environment. Transportation of imported coal will be done in covered trucks. Coal will be fed into boiler by closed conveyor belt. All the precautions for storage and handling of coal will be

followed as per coal handling guideline.

Annexure-1: Land Document

Form-3

Application for Amendment in TOR

1 Details of Project a. Name of the Project (s) : Manufacturing of API & Intermediate

Pharmaceutical Products

b. Name of the Company / Organization : Richmond Research & Pharmaceuticals LLP

c. Registered Address : C/o 23, Tulsi Bungalows, Sola Science City Road, near Mahadev Temple, Sola, Ahmedabad PIN 380060

d. Legal Status of the Company : Registered Company

e. Joint Venture (Yes/No) : No

If Yes,

(i) No. of JV Partners (Multiple Entries Allowed) :

Name of the JV

Partner Share of the JV Partner

Address of the JV Partner

Email Id of JV Partner

Mobile No. of JV Partner

Not Applicable

2 Address for the correspondence

a. Name of the applicant : Mr Snehal Vishnubhai Patel

b. Designation (Owner / Partner / CEO) : Partner

c. Address : C/o 23, Tulsi Bungalows, Sola Science City Road, near Mahadev Temple, Sola, Ahmedabad PIN

d. Pin code : 380060

e. e-mail : [email protected]

f. Telephone No. : 9574008795

g. Fax No. : -

3 Category of the Project/Activity as per Schedule of EIA Notification, 2006

a. Project / Activity

[1(a)(i) / 1(a)(ii) / l(b) / l(c) / l(d) / 1 (e) / 2(a) / 2(b) / 3(a) / 3(b) / 4(a)

/ 4(b)(i)/4(b) (ii) / 4(c) / 4(d) / 4(e) / 4(f) / 5(a) / 5(b) / 5(c) / 5(d) /

5(e) / 5(f) / 5(g) / 5(h) / 5(i)/ 5(j) / 6(a) / 6(b) / 7(a) / 7(b)/ 7 (c) /

7 (d) / 7 (da) / 7 (e) / 7 (f) / 7 (g) / 7 (h) / 7 (i) /8 (a) /8 (b)

: 5(f)

b. Category (A/B1/B2) : B1

If B1 or B2

Reason for application at Central Level/State level (in case of B2 projects)

If Others

c. Please Specify :

d. EAC concerned (for category A Projects only)

(Coal Mining/Non-coal Mining /Thermal/River Valley & Hydro / Industry-I / Industry-II / Infrastructure-I / Infrastructure-II /Nuclear & Defense /CRZ

: -

e. New/Expansion / Modernization / One Time Capacity expansion (only for Coal Mining) /Expansion under Para 7(ii)/Modernization under Para 7(ii) / Change of Product Mix under Para 7(ii)

: New

4 Location of the Project

a. Plot /Survey / Khasra No. : Survey No: 137

b. Village : Govindpura

c. Tehsil : Kadi

d. District : Mehsana

e. State : Gujarat

f. Pin Code 382170

g. Bounded Latitudes (North)

From 23° 5'36.25"N 23° 5'36.55"N

To 72°18'19.12"E 72°18'16.87"E

h. Bounded Longitudes (East)

From 23° 5'35.08"N 23° 5'35.36"N

To 72°18'18.96"E 72°18'16.58"E

i. Survey of India Topo Sheet No. F43A4, F43A8

j. Upload Topo Sheet File (Upload pdf only) Will be provided in EIA Report.

k. Maximum Elevation Above Means Sea Level (AMSL) 44 m

l. Upload (kml) File (Upload kml only) Was uploaded at the time of Form-1.

m. Distance of Nearest HFL from the project boundary within the study area

n. Seismic Zone (zone: 1 / 2 / 3 / 4 / 5) 3

5 Details of Terms of Reference

a. Date of issue of TOR : 29-01-2019

b. MoEF&CC/ SEIAA file No. : SEIAA/GUJ/TOR/5(f)/183/2019

c. Upload TOR Letter (PDF only) : Uploaded.

6 Details of Product

Product/ Activity (Capacity / Area)

Quantity as per Approved TOR

Quantity Proposed Unit Mode of Transport/ Transmission of Product

Chlorhexidine Base 12.50 - MT/Month By Road

Chlorhexidine Digluconate

2.08 - MT/Month By Road

Chlorhexidine Diacetate

2.08 - MT/Month By Road

Chlorhexidine Hydrochloride

2.08 - MT/Month By Road

Trimethyl sulfoxonium Iodide

2.50

- MT/Month By Road

Methyl Iodide 2.08 - MT/Month By Road

Sildenafile citrate 0.83 - MT/Month By Road

Celecoxib 0.83 - MT/Month By Road

- Unit:- (Tons per Annum (TPA), Mega Watt (MW), Hectares (ha), Kilo Litre per Day (KLD), Tons Crushed per

Day (TCD), Cubic Meter per Day, Kilometers (km), Million Liters per Day (MLD), (Others) - Mode of Transport/ Transmission of product (Road, Rail, Conveyor Belt, Pipe Conveyor, Arial Ropeway,

Combination of two or three modes, others)

7 Details of Configuration (Multiple Entries Allowed)

Plant/Equipment/Facility Existing Configuration

Proposed Configuration

Final Configuration after Amendment

Remarks if any

-- -- -- -- -- -- -- -- -- --

8 Reasons for the amendment in TORs: 1) Change in company name from Richmond Pharmaceuticals & Research LLP to Richmond

Research & Pharmaceuticals LLP. 2) Fuel change in IBR boiler from Diesel to Imported Coal/ Bio-Coal. 3) Addition of DG Set Stack.

9 Any Other Amendment required

Reference of approved ToR

Description as per approved ToR

Description as per proposal

Remarks

Page No: 1, Name of Company: Name of Company: Land Document uploaded.

Richmond Pharmaceuticals & Research LLP

Richmond Research & Pharmaceuticals LLP

Page No: 2, Section E Fuel in IBR Boiler: Diesel Change in fuel in IBR Boiler from Diesel to Imported Coal/ Bio-Coal

Page No: 2, Section E Only one stack of IBR Boiler

Addition of one stack of DG Set.

After TOR Amendment, there will be 2 stacks.

10 Details of EIA Consultant

a) Have you hired Consultant for preparing document (Yes/No)? Yes

If No, Not Applicable

(1) Reason for not engaging the Consultant

If Yes,

a) Accreditation No. NABET/EIA/1619/RA 0042

b) Name of the EIA Consultant Kadam Environmental Consultants

c) Address 871/B/3, GIDC Makarpura, Vadodara-390010, Gujarat

d) Mobile No. 9714861611

e) Landline No. 0265-2653912

f) E-mail Id [email protected]

g) Category of Accreditation (Eligible for Category A / Eligible for Category (B)

A

h) Sector of Accreditation 1(d)

i) Validity of Accreditation 15.10.2019

j) Upload Certificate of Accreditation certified by QCI/NABET (Upload pdf Only)

39 Documents to be attached

a. Upload copy of revised Form-1 Uploaded

b. Upload Revised Pre-Feasibility Report Uploaded

c. Upload Cover Letter duly signed by the project proponent or authorized Person

Uploaded

d. Upload a copy of authorization duly signed by the project proponent in support of the person making this application on behalf of the user agency (upload pdf only)

e. Upload additional File, if any(upload pdf only)

40 Undertaking

a. I hereby give undertaking that the data and information given in the application and enclosures are true to be best of my knowledge and belief and I am aware that if any part of the data and information found to be false or misleading at any stage, the project will be rejected and clearance given, if any to the project will be revoked at our risk and cost. In addition to above, I hereby give undertaking that no activity / construction / expansion has since been taken up

b. Name Mr. Snehal Patel

c. Designation Partner

d. Company Richmond Research & Pharmaceuticals LLP

e. Address Survey No: 137, Village: Govindpura, Taluka Kadi, District Mehsana-382170

Richmond Research &

Pharmaceuticals LLP

Form-1 for API & Intermediate Pharmaceutical Products at Survey No. 137, Village Govindpura, Taluka Kadi, District Mehsana-382170

JUNE, 2019

Kadam Environmental Consultants

w w w . ka d a m en v i r o . c o m

Envi ronment for Deve lopment

RICHMOND RESEARCH & PHARMACEUTICALS LLP

FORM-1 FOR API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILLAGE GOVINDPURA, TALUKA KADI, DISTRICT

MEHSANA-382170 FORM I

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 2

Richmond Research & Pharmaceuticals LLP

Form-1 for API & Intermediate Pharmaceutical Products at Village Govindpura, Taluka Kadi, District Mehsana-382170 © Kadam Environmental Consultants (‘Kadam’), June, 2019

This report is released for the use of the Bostik, Regulators and relevant stakeholders solely as

part of the subject project’s Environmental Clearance process. Information provided (unless

attributed to referenced third parties) is otherwise copyrighted and shall not be used for any other

purpose without the written consent of Kadam.

PROJECT DETAILS

Name of

Publication

Form-1 for for API & Intermediate Pharmaceutical Products at Village Govindpura, Taluka

Kadi, District Mehsana-382170

Project

Number 1938062106

Report

No. 1 Version 01 Released June,2019

Prepared &

Managed By

Shweta Rajput &

Bhavin Jambucha Released By Sangram Kadam

CONTACT DETAILS

Vadodara (Head Office)

871/B/3, GIDC Makarpura, Vadodara, India – 390 010.

E: [email protected]; T:+91-265-3001000; F: +91-265-3001069

Delhi / NCR

Spaze IT Park, Unit No. 1124, 11th Floor, Tower B-3, Sector 49, Sohna Road, Gurgaon, India – 122 002

E: [email protected]; T/F : 0124-424 2430-436

DISCLAIMER

Kadam has taken all reasonable precautions in the preparation of this report as per its auditable quality

plan. Kadam also believes that the facts presented in the report are accurate as on the date it was

written. However, it is impossible to dismiss absolutely, the possibility of errors or omissions. Kadam

therefore specifically disclaims any liability resulting from the use or application of the information

contained in this report. The information is not intended to serve as legal advice related to the individual

situation.

RICHMOND RESEARCH & PHARMACEUTICALS LLP

FORM-1 FOR API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILLAGE GOVINDPURA, TALUKA KADI, DISTRICT MEHSANA-382170 FORM I

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 3

CONTENTS

1 SCOPING ........................................................................................................ 4

RICHMOND RESEARCH & PHARMACEUTICALS LLP

FORM-1 FOR API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILLAGE GOVINDPURA, TALUKA KADI, DISTRICT MEHSANA-382170 FORM I

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 4

1 SCOPING

The scoping for the project has been done based on FORM 1, as per EIA Notification, dated September 14,

2006 amended as on date. The scoping details are as follows:

I. Basic Information

S.

No. Item Details

1 Name of the Project/s Manufacturing of API & Intermediate Pharmaceutical

Products

2 S. No. in the Schedule 5(f)

3

Proposed capacity / area / length / tonnage to be

handled/ command area / lease area / no. of wells to

be drilled

2,681 m2

4 New / Expansion / Modernization New

5 Existing Capacity / Area etc. Not Applicable

6 Category of Project (A or B) B

7 Does it attract the general conditions? If yes, please

specify. No

8 Does it attract specific condition? If yes, please

specify No

9

Location

Plot Survey / Khasra No. Survey No: 137

Village Govindpura

Tehsil / Taluka / Mandal Kadi

District Mehsana

State Gujarat

10 Nearest railway station / airport / along with distance

in km.

Railway Station

Sabarmati Railway Station: ~28.79 km (ESE Direction)

Airport

Ahmedabad Airport: ~31.92 km (ESE Direction)

11 Nearest town, city, district headquarters along with

distances in km Kadi District:

12

Village Panchayat, Zila Parisad, Municipal Corporation,

Local Body (complete postal address with telephone

nos. to be given)

13 Name of the applicant Richmond Research & Pharmaceuticals LLP

14 Registered address C/o 23, Tulsi Bungalows, Sola Science City Road, near

Mahadev Temple, Sola, Ahmedabad PIN 380060

15

Address for correspondence

Name Mr Snehal Vishnubhai Patel

Designation Partner

Address C/o 23, Tulsi Bungalows, Sola Science City Road, near

Mahadev Temple, Sola, Ahmedabad PIN

RICHMOND RESEARCH & PHARMACEUTICALS LLP

FORM-1 FOR API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILLAGE GOVINDPURA, TALUKA KADI, DISTRICT MEHSANA-382170 FORM I

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 5

S.

No. Item Details

Pin Code 380060

E-mail [email protected]

Telephone no. 9574008795

Fax no. -

16 Details of alternative sites examined, if any. Location

of these sites should be shown on the Toposheet Yes

17 Interlinked Projects No

18 Whether separate application of interlinked project

has been submitted? No

19 If yes, date of submission Not Applicable

20 If no, reason We have studied the alternative sites and found this site

more suitable for project

21

Whether the proposal involves approval / clearance

under: if yes, details of the same and their status to

be given:

The Forest (Conservation) Act, 1980

The Wildlife (Protection) Act, 1972

The C.R.Z Notification, 1991

Not applicable

22 Whether there is any Government order / policy,

relevant / relating to the site Not Applicable

23 Forest land involved (ha.) Not applicable

24

Whether there is any litigation pending against the

project and / or land in which the project is proposed

to be set up?

Name of the Court

Case No. Order / directions of the Court, if any and

its relevance with the proposed project

Not Applicable

RICHMOND RESEARCH & PHARMACEUTICALS LLP

FORM-1 FOR API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILLAGE GOVINDPURA, TALUKA KADI, DISTRICT MEHSANA-382170 FORM I

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 6

II. Activity

1. Construction, operation or decommissioning of the project involving actions, which

will cause physical changes in the locality (topography, land use, changes in water

bodies, etc.)

S.

No. Information/Checklist Confirmation

Yes /

No?

Details thereof (with approximate

quantities / rates, wherever possible) with

source of information data

1.1

Permanent or temporary change in land

use, land cover or topography including

increase in intensity of land use (with

respect to local land use plan)

Yes

The land is changed for use as industrial purpose.

Total land area for proposed project is 2,681 sqm.

The Land Ownership Document is enclosed in

PFR.

1.2 Clearance of existing land, vegetation and

buildings? Yes

The land cleaning is required to remove the weed

plants inside the area. The site is clear in all

aspects.

1.3 Creation of new land uses? Yes

The land will be used as Industrial use. The Non-

Agriculture Use Approval order is obtained and the

NA order is provided in PFR.

1.4 Pre-construction investigations e.g. bore

houses, soil testing? Yes

We will carry out the necessary pre- construction investigation tests including soil bearing capacity

of the soil.

1.5 Construction works? Yes

Civil Construction work is required for Installing Plants, Equipment, Machineries, and Storage

area for Raw Material, Product and Waste Management.

1.6 Demolition works? No Not Applicable

1.7 Temporary sites used for construction works

or housing of construction workers? No Not Applicable

1.8

Above ground buildings, structures or

earthworks including linear structures, cut

and fill or excavations Yes

On and Above Ground Floor Civil Construction work is required for Installing Plants, Equipment, Machineries, and Storage area for Raw Material,

Product and Waste Management

1.9 Underground works including mining or

tunneling? No Not applicable

1.10 Reclamation works? No Not applicable

1.11 Dredging? No Not applicable

1.12 Offshore Structure? No Not applicable

1.13 Production and manufacturing processes? Yes Provided in PFR Chapter , Section

1.14 Facilities for storage of goods or materials? Yes Details of storage of goods will be provided in EIA

Report.

1.15 Facilities for treatment or disposal of solid

waste or liquid effluents? Yes

The Sewage will be treated and disposed of through Septic Tank and Soak Well. The Industrial Waste water generated will be segregated based on organic and inorganic contents. The organic content wastewater generated from process (high concentrated stream) and washings (low concentrated stream) will be collected in organic effluent sump. The organic stream will be neutralized, get settled solids in two another sumps. The neutralized organic effluent will be transferred to final organic effluent sump and will be sent to Authorized Common Incineration Facility. The sludge from the bottom of the sump will be collected once in 1 to 6 months and will be dried, bagged & stored in ETP Sludge storage yard. The

RICHMOND RESEARCH & PHARMACEUTICALS LLP

FORM-1 FOR API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILLAGE GOVINDPURA, TALUKA KADI, DISTRICT MEHSANA-382170 FORM I

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 7

S.

No. Information/Checklist Confirmation

Yes /

No?

Details thereof (with approximate

quantities / rates, wherever possible) with

source of information data

ETP sludge will be sent to Authorized TSDF site.

The inorganic effluent from Cooling tower, Boiler, Scrubber and RO Reject will be collected in Inorganic Effluent Sump. The pH will be corrected and solid liquid separation will be carried out in Settling tank. The clear effluent will be collected in the Inorganic Intermediate Storage Sump. The pre- Treatment will be provided including PSF, ACF followed with UF or MF to feed to Two Stage RO. The permeate will be recycled in the make up for Cooling, Boiler and Scrubber. The reject effluent will be charged to MEE / Thermal Evaporator. The sludge will be collected, bagged and stored in ETP Storage yard. The Sludge will be sent to Authorized TSDF site

1.16 Facilities for long term housing of

operational workers? No Not applicable

1.17 New road, rail or sea traffic during

construction or operation? No Not applicable

1.18

New road, rail, air waterborne or other

transport infrastructure including new or

altered routes and stations, ports, airports

etc?

No Not applicable

1.19

Closure or diversion of existing transport

routes or infrastructure leading to changes

in traffic movements?

No Not applicable

1.20 New or diverted transmission lines or

pipelines? No Not applicable

1.21

Impoundment, damming, culverting,

realignment or other changes to the

hydrology of watercourses or aquifers? No Not applicable

1.22 Stream crossings? No Not applicable

1.23 Abstraction or transfers of water from

ground or surface waters? Yes The Ground water will be abstracted for domestic

and industrial purpose.

1.24 Changes in water bodies or the land surface

affecting drainage or run-off? No Not Applicable

1.25

Transport of personnel or materials for

construction, operation or

decommissioning? Yes

Estimated maximum of 185 (MT/Month) material handling will be carried out at maximum capacity

handling for raw materials, liquid and solid products including hazardous/solid waste for

transportation

1.26 Long-term dismantling or decommissioning

or restoration works? No Not Applicable

1.27

Ongoing activity during decommissioning

which could have an impact on the

environment?

No Not Applicable

1.28 Influx of people to an area either

temporarily or permanently? No Not Applicable

1.29 Introduction of alien species? No Not Applicable

1.30 Loss of native species or genetic diversity? No Not Applicable

RICHMOND RESEARCH & PHARMACEUTICALS LLP

FORM-1 FOR API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILLAGE GOVINDPURA, TALUKA KADI, DISTRICT MEHSANA-382170 FORM I

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 8

S.

No. Information/Checklist Confirmation

Yes /

No?

Details thereof (with approximate

quantities / rates, wherever possible) with

source of information data

1.31 Any other actions? No Not Envisaged

2. Use of Natural resources for construction or operation of the Project (such as land,

water, materials or energy, especially any resources which are non-renewable or in

short supply):

S.

No. Information/Checklist confirmation

Yes /

No?

Details thereof (with approximate

quantities / rates, wherever possible) with

source of information data

2.1 Land especially undeveloped or agricultural

land (ha) Yes

The land is for industrial use purpose. The area of

the project is 2,681 m2.

2.2 Water (expected source & competing users)

unit: KLD Yes

Source: Ground Water

Fresh Consumption: 17.98 KLD.

2.3 Minerals (MT) No Not applicable

2.4 Construction material stone, aggregates, sand

/ soil (expected source, MT) Yes Cement, Steel, Stone, Sand, Kapchi, Bricks,

wood, HDPE etc.

2.5 Forests and timber (source, MT) No Not applicable

2.6 Energy including electricity and fuels (source,

competing users) unit: fuel (MT), energy (MW) Yes

Electricity: Uttar Gujarat Vij Co. Ltd. for demand of 140 KW for proposed project.

Fuel: 1.2 MT/Day Bio-coal OR 2 MT/Day

Imported Coal will be used as fuel in 500 kg/hr Steam capacity Industrial Small Boiler.

30 kg/hr Diesel will be used as fuel in 125 KVA

DG set (only for emergency use only).

2.7 Any other natural resources (use appropriate

standard units) No Not Envisaged

3. Use, storage, transport, handling or production of substances or materials, which

could be harmful to human health or the environment or raise concerns about actual

or perceived risks to human health.

S.

No. Information / Checklist confirmation

Yes /

No?

Details thereof (with approximate

quantities / rates, wherever possible) with

source of information data

3.1

Use of substances or materials, which are

hazardous (as per MSIHC rules) to human

health or the environment (flora, fauna, and

water supplies)

Yes All the Hazardous chemicals will be handled &

stored as per MHISC Rules.

3.2

Changes in occurrence of disease or affect

disease vectors (e.g. insect or water borne

diseases) No Not Applicable

3.3 Affect the welfare of people e.g. by changing

living conditions? No Not Applicable

3.4

Vulnerable groups of people who could be

affected by the project e.g. hospital patients,

children, the elderly etc., No Not Applicable

3.5 Any other causes No Not Applicable

RICHMOND RESEARCH & PHARMACEUTICALS LLP

FORM-1 FOR API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILLAGE GOVINDPURA, TALUKA KADI, DISTRICT MEHSANA-382170 FORM I

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 9

4. Production of solid wastes during construction or operation or decommissioning

(MT/month)

S.

No. Information/Checklist confirmation Yes /No?

Details thereof (with approximate

quantities / rates, wherever possible) with

source of information data

4.1 Soil, overburden or mine wastes No Not Applicable

4.2 Municipal waste (domestic and or commercial

wastes) Yes

Municipal Waste

Waste paper from administration buildings,

waste metals etc.

Disposal method

Waste paper will be given to recyclers.

4.3 Hazardous wastes (as per Hazardous Waste

Management Rules) Yes

Details of hazardous wastes are given in PFR

Chapter 3, Section 3.11.3

4.4 Other industrial process wastes No Not Applicable

4.5 Surplus product No Not Applicable

4.6 Sewage sludge or other sludge from effluent

treatment No Not Applicable

4.7 Construction or demolition wastes No Not Applicable

4.8 Redundant machinery or equipment No Not Applicable

4.9 Contaminated soils or other materials No Not Applicable

4.10 Agricultural wastes No Not Applicable

4.11 Other solid wastes No Not Applicable

5. Release of pollutants or any hazardous, toxic or noxious substances to air (kg/hr)

S.

No. Information/Checklist confirmation

Yes

/No?

Details thereof (with approximate

quantities / rates, wherever possible) with

source of information data

5.1 Emissions from combustion of fossil fuels

from stationary or mobile sources Yes

Details of flue gas emissions are given in PFR,

Chapter 3, Section 3.11.1

5.2 Emissions from production processes Yes Details of process gas emissions are given in PFR,

Chapter 3, Section 3.11.1

5.3 Emissions from materials handling including

storage or transport Yes

Coal dust generation is anticipated from coal

storage and handling. Arrangements for wetting

and water spray/extraction of emission from

transfer points will be provided as per GPCB

Guidelines.

5.4 Emissions from construction activities

including plant and equipment Yes

Emissions from exhausts of diesel operated

vehicles, concrete mixers and excavators are

anticipated. However, these equipment will be

maintained properly to ensure minimum

emissions and vehicles with Pollution Under

Control (PUC) certificates will be used

5.5

Dust or odors from handling of materials

including construction materials, sewage and

waste

Yes

Dust

Dust will be generated during handling of

construction materials; these will be controlled by

sprinkling of water.

Odor

Appropriate odor control measures shall be

installed which will be detailed in the EIA report.

5.6 Emissions from incineration of waste No Not Envisaged

RICHMOND RESEARCH & PHARMACEUTICALS LLP

FORM-1 FOR API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILLAGE GOVINDPURA, TALUKA KADI, DISTRICT MEHSANA-382170 FORM I

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 10

S.

No. Information/Checklist confirmation

Yes

/No?

Details thereof (with approximate

quantities / rates, wherever possible) with

source of information data

5.7 Emissions from burning of waste in open air

(e.g. slash materials, construction debris) No Not Envisaged

5.8 Emissions from any other sources No Not Applicable

6. Generation of Noise and Vibration, and Emissions of Light and Heat:

S.

No. Information/Checklist confirmation

Yes /

No?

Details thereof (with approximate

quantities / rates, wherever possible) with

source of information data

6.1 From operation of equipment e.g. engines,

ventilation plant, crushers Yes

The equipment like dryers, centrifuge, boiler and prime movers will be sources of vibration

and noise.

The heat emission @ 120-135oC temperature

will from flue gas emission through chimney attached to the small industrial boiler.

6.2 From industrial or similar processes Yes Noise will be generated during Industrial process, handling and material transfer.

6.3 From construction or demolition Yes Noise will be generated during excavation,

plant equipment installation.

6.4 From blasting or piling No Not applicable

6.5 From construction or operational traffic Yes Noise will be generated during

construction and operational traffic.

6.6 From lighting or cooling systems Yes Due to Cooling fan

6.7 From any other sources No Not applicable

7. Risks of contamination of land or water from releases of pollutants into the ground or

into sewers, surface waters, groundwater, coastal waters or the sea

S.

No. Information/Checklist confirmation

Yes /

No?

Details thereof (with approximate

quantities / rates, wherever possible) with

source of information data

7.1 From handling, storage, use or spillage of

hazardous materials Yes

Occasional & minor spillage of chemicals or other

materials may occur. These will not cause any

impact on water or land due to adoption of

adequate spill control measures. Storage will be

on paved area.

7.2

From discharge of sewage or other effluents to

water or the land (expected mode and place of

discharge)

No

Not Applicable as treated effluent will be

completely reused within premises and sewage

will be disposed off into soak pit.

7.3 By deposition of pollutants emitted to air into

the land or into water No

Adequate stack height and good engineering

practices will be ensured to reduce the impacts

due to emission of air pollutants leading to

deposition to air, into the land or into water.

7.4 From any other sources No None identified

7.5

Is there a risk of long term build up of

pollutants in the environment from these

sources?

No

Adequate mitigation measures, monitoring and

periodic maintenance of equipment will be

ensured so that there is no risk of long term

buildup of pollutants in the environment.

RICHMOND RESEARCH & PHARMACEUTICALS LLP

FORM-1 FOR API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILLAGE GOVINDPURA, TALUKA KADI, DISTRICT MEHSANA-382170 FORM I

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 11

8. Risk of accidents during construction or operation of the Project, which could affect

human health or the environment

S.

No. Information/Checklist confirmation

Yes /

No?

Details thereof (with approximate

quantities / rates, wherever possible) with

source of information data

8.1

From explosions, spillages, fires etc from

storage, handling, use or production of

hazardous substances

Yes

The associated hazards from the plant are

toxic release and fire. These hazards can

take place due to process upsets, leakages,

equipment and hardware failures, loss of

containment, human failures etc.

Adequate safety measures will be provided to

prevent risk of explosions, spillages, fires etc.

8.2 From any other causes No No other cause envisaged.

8.3

Could the project be affected by natural

disasters causing environmental damage e.g.

floods, earthquakes, landslides, cloudburst

etc)?

Yes

Floods

Heavy monsoons occasionally cause floods,

but the site elevation at the project area

ensures that there is no impact of floods in

the area.

Earthquakes

The area comes under the moderate

risk zone (Zone-III) of the

Seismic Zonation. The design of structures at

the project site shall be based on IS 1893 to

make it earthquake resistant.

Landslides

Not noted to occur in the area.

Cloudburst

Not a known feature in the study area

9. Factors which should be considered (such as consequential development) which could

lead to environmental effects or the potential for cumulative impacts with other

existing or planned activities in the locality

S.

No. Information/Checklist confirmation

Yes /

No?

Details thereof (with approximate

quantities/ rates, wherever possible) with

source of information data

9.1

Lead to development of supporting Facilities,

ancillary development or development

stimulated by the project which could have

impact on the environment e.g.: supporting

infrastructure (roads, power supply, waste or

waste water treatment, etc.) housing

development extractive industries supply

industries, (other)

Yes

Development of Supporting Facilities

No additional support facility will require

because adequate supporting facilities are

already available in the vicinity of the site and

infrastructure (water, roads, treated effluent

collection and disposal facilities) already

existing in the area are adequate to take care

of all requirements of the project.

9.2 Lead to after-use of the site, which could

have an impact on the environment No Not Applicable

9.3 Set a precedent for later developments Yes

It is expected that the proposed project will set

high standards of process safety and

environmental excellence.

9.4

Have cumulative effects due to proximity to

other existing or planned projects with similar

effects

No Not Applicable

RICHMOND RESEARCH & PHARMACEUTICALS LLP

FORM-1 FOR API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILLAGE GOVINDPURA, TALUKA KADI, DISTRICT MEHSANA-382170 FORM I

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 12

III. Environmental Sensitivity

S.

No. Information/Checklist confirmation

Yes /

No?

Aerial distance (within 15 km.) of

Proposed Project location boundary

1

Areas protected under international

conventions, national or local legislation for

their ecological, landscape, cultural or other

related value

Yes Thor Lake :- 8.47 km in ENE Direction

2

Areas which are important or sensitive for

ecological reasons - Wetlands, watercourses or

other water bodies, coastal zone, biospheres,

mountains, forests

Yes

There is no such wetlands, coastal zone,

biosphere, mountain, forests within the study

area.

Water Body

Thor Lake: ~8.47 km in ENE Direction

3

Areas used by protected, important or

sensitive species of flora or fauna for breeding,

nesting, foraging, resting, over wintering,

migration

None No such area exist within 15 km radius of the

proposed project site.

4 Inland, coastal, marine or underground waters No Not Identified

5 State, National boundaries No Not Applicable

6

Routes or facilities used by the public for

access to recreation or other tourist, pilgrim

areas

No Not Applicable

7 Defense installations No Not Applicable

8 Densely populated or built-up area Yes

Khanderavpura Village: ~1.21 km in NNE

Direction

Govindpura Village: ~1.43 km in WSW Direction

9

Areas occupied by sensitive man-made land

uses (hospitals, schools, places of worship,

community facilities)

No Not Applicable

10

Areas containing important, high quality or

scarce resources (ground water resources,

surface resources, forestry, agriculture,

fisheries, tourism, minerals)

No Not Applicable

11

Areas already subjected to pollution or

environmental damage. (Those where existing

legal environmental standards are exceeded)

None None identified

12

Areas susceptible to natural hazard which

could cause the project to present

environmental problems (earthquakes,

subsidence, landslides, erosion, flooding or

extreme or adverse climatic conditions)

Yes Refer Point No. 8.3 above

“I hereby given undertake that the data and information given in the application and enclosures are true to

the best of my knowledge and belief and I am aware that if any part of the data and information submitted is

found to be false or misleading at any stage, the project will be rejected and clearance given, if any project

will be revoked at our risk and cost.”

Date: 24-06-2019

Place: Ahmedabad

Name: Mr. Snehal Patel

Designation: Partner

Address: C/0 23, Tulsi Bungalows,

Sola Science City Road, near Mahadev

Temple, Sola, Ahmedabad-380060

RICHMOND RESEARCH &

PHAMACEUTICALS LLP

Pre-feasibility Report: Environmental Clearance for API & Intermediate Pharmaceutical Products at Survey No. 137, Village Govindpura, Taluka Kadi, District Mehsana-382170.

APRIL, 2019

Kadam Environmental Consultants w w w . ka d a m en v i r o . c o m

Envi ronment for Deve lopment

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 2

RICHMOND RESEARCH & PHARMACEUTICALS LLP

Prefeasibility Report for Proposed API & Intermediate Pharmaceuticals Products at Survey No: 137, Village Govindpura, Taluka Kadi, District Mehsana-382170. © Kadam Environmental Consultants (‘Kadam’), April, 2019

This report is released for the use of the Client Name, Regulators and relevant stakeholders solely as

part of the subject project’s Environmental Clearance process. Information provided (unless attributed

to referenced third parties) is otherwise copyrighted and shall not be used for any other purpose

without the written consent of Kadam.

PROJECT DETAILS

Name of

Publication Prefeasibility Report for Proposed API & Intermediate Pharmaceuticals Products at Survey

No: 137, Village Govindpura, Taluka Kadi, District Mehsana-382170

Project Number Report No. Version 1 Released April, 2019

Prepared &

Managed By Shweta Rajput Released By Sangram Kadam

CONTACT DETAILS

Vadodara (Head Office)

871/B/3, GIDC Makarpura, Vadodara, India – 390 010.

E: [email protected]; T:+91-265-3001000; F: +91 265 300106

Delhi / NCR

SPAZE IT PARK, Unit no. 1124, 11th Floor, Tower B 3, Sector 49, Near Omaxe City Centre mall,

Sohna Road, Gurgaon -122 002 (Haryana)

E: [email protected]; T: 0124-4242430; M:+91-98998-04300

DISCLAIMER

Kadam has taken all reasonable precautions in the preparation of this report as per its auditable quality plan. Kadam also believes that the facts presented in the report are accurate as on the date it was written. However, it is impossible to dismiss absolutely, the possibility of errors or omissions. Kadam therefore specifically disclaims

any liability resulting from the use or application of the information contained in this report. The information is not intended to serve as legal advice related to the individual situation.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 3

CONTENTS

1 EXECUTIVE SUMMARY ................................................................................. 6

1.1 PLANT FEATURES AND PRODUCTION CAPACITY .......................................................... 6

2 INTRODUCTION .......................................................................................... 7

2.1 IDENTIFICATION FOR PROJECT PROPONENT & PROPOSED PROJECT ..................................... 7

2.1.1 Project Proponent ................................................................................ 7

2.1.2 Proposed Project ................................................................................. 7

2.2 BRIEF DESCRIPTION OF THE PROJECT .................................................................... 7

2.3 NEED FOR THE PROJECT AND IT’S IMPORTANCE TO REGION .............................................. 7

2.4 DEMAND SUPPLY GAP .................................................................................... 7

2.5 IMPORT VS. INDIGENOUS PRODUCTION .................................................................. 7

2.6 EXPORT POSSIBILITY ..................................................................................... 7

2.7 EMPLOYMENT GENERATION (DIRECT AND INDIRECT) DUE TO THE PROJECT. ............................ 8

3 PROJECT DESCRIPTION ............................................................................... 9

3.1 TYPE OF PROJECT ........................................................................................ 9

3.2 LOCATION (MAP SHOWING GENERAL LOCATION, SPECIFIC LOCATION AND PROJECT BOUNDARY &

PROJECT LAY OUT) WITH COORDINATES .......................................................................... 9

3.3 DETAILS OF ALTERNATE SITES CONSIDERED AND THE BASIS OF SELECTING THE PROPOSED SITE,

PARTICULARLY THE ENVIRONMENTAL CONSIDERATIONS GONE INTO SHOULD BE HIGHLIGHTED ................ 10

3.4 SIZE OR MAGNITUDE OF OPERATION................................................................... 10

3.5 TECHNOLOGY AND PROCESS DESCRIPTION ............................................................ 12

3.5.1 Manufacturing process for Chlorhexidine base: ........................................... 12

3.5.2 Manufacturing process for chlorhexidine digluconate: ................................... 15

3.5.3 Manufacturing process for chlorhexidine diacetate: ...................................... 16

3.5.4 Manufacturing process for chlorhexidine dihydrochloride: .............................. 17

3.5.5 Manufacturing process for Trimethyl sulfoxonium iodide: ............................... 11

3.5.6 Manufacturing process for Methyl iodide: .................................................. 12

3.5.7 Manufacturing process for sildenafil citrate: ............................................... 13

3.5.8 Manufacturing process for celecoxib: ....................................................... 14

3.6 RAW MATERIALS ....................................................................................... 17

3.7 PROCESS DESCRIPTION ................................................................................ 18

3.8 ADDITIVES AND CHEMICALS ............................................................................ 18

3.9 RAW MATERIAL REQUIRED ALONG WITH ESTIMATED QUANTITY, LIKELY SOURCE, MARKETING AREA OF

FINAL PRODUCTS, MODE OF TRANSPORT OF RAW MATERIAL AND FINISHED PRODUCT. ......................... 18

3.10 AVAILABILITY OF WATER ITS SOURCE, ENERGY/POWER REQUIREMENT AND SOURCE SHOULD BE GIVEN

18

3.10.1 Power Requirement ............................................................................ 18

3.10.2 Water consumption ............................................................................ 18

3.10.3 Fuel ............................................................................................... 19

3.11 QUANTITY OF WASTE TO BE GENERATED (LIQUID AND SOLID) AND SCHEME FOR THEIR MANAGEMENT

/DISPOSAL ...................................................................................................... 19

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 4

3.11.1 Air Emissions .................................................................................... 19

3.11.2 Wastewater Generation ....................................................................... 19

3.11.3 Hazardous waste Generation and Disposal Details ....................................... 20

3.12 WASTEWATER TREATMENT FACILITY ................................................................ 20

4 SITE ANALYSIS ......................................................................................... 21

4.1 CONNECTIVITY ......................................................................................... 21

4.1.1 By Road .......................................................................................... 21

4.1.2 By Rail ........................................................................................... 21

4.1.3 By Air ............................................................................................ 21

4.2 LAND FORM, LAND USE AND LAND OWNERSHIP ........................................................ 21

4.3 TOPOGRAPHY (ALONG WITH MAP) ...................................................................... 21

4.4 EXISTING LAND USE PATTERN (AGRICULTURE, NON-AGRICULTURE, FOREST, WATER BODIES (INCLUDING

AREA UNDER CRZ)), SHORTEST DISTANCES FROM THE PERIPHERY OF THE PROJECT TO PERIPHERY OF THE

FORESTS, NATIONAL PARK, WILD LIFE SANCTUARY, ETC SENSITIVE AREAS, WATER BODIES (DISTANCE FROM THE

HFL OF THE RIVER), CRZ. IN CASE OF NOTIFIED INDUSTRIAL AREA, A COPY OF THE GAZETTE NOTIFICATION

SHOULD BE GIVEN. ............................................................................................. 23

4.5 SOIL CLASSIFICATION .................................................................................. 24

4.6 CLIMATIC DATA FROM SECONDARY SOURCES ........................................................... 24

4.7 SOCIAL INFRASTRUCTURE AVAILABLE ................................................................... 26

5 PLANNING BRIEF ...................................................................................... 27

5.1 PLANNING CONCEPT .................................................................................... 27

5.2 POPULATION PROJECTION .............................................................................. 27

5.3 LAND USE PATTERN .................................................................................... 27

5.4 ASSESSMENT OF INFRASTRUCTURE DEMAND (PHYSICAL & SOCIAL) ................................... 27

5.5 AMENITIES/FACILITIES ................................................................................. 27

5.5.1 Education: ....................................................................................... 27

5.5.2 Medical & Health ............................................................................... 27

5.5.3 Power & Water ................................................................................. 27

5.5.4 Rail and Road ................................................................................... 28

6 PROPOSED INFRASTRUCTURE .................................................................... 29

6.1 INDUSTRIAL AREA (PROCESSING AREA) ................................................................ 29

6.2 RESIDENTIAL AREA (NON-PROCESSING AREA) ......................................................... 29

6.3 GREEN BELT ............................................................................................ 29

6.4 SOCIAL INFRASTRUCTURE .............................................................................. 29

6.5 CONNECTIVITY (TRAFFIC AND TRANSPORTATION ROAD/ RAIL/METRO/WATER WAYS ETC). ............ 29

6.6 DRINKING WATER MANAGEMENT (SOURCE & SUPPLY OF WATER) ...................................... 29

6.7 SEWAGE SYSTEM ....................................................................................... 29

6.8 INDUSTRIAL WASTE MANAGEMENT ..................................................................... 29

6.9 SOLID WASTE MANAGEMENT ............................................................................ 30

6.10 POWER REQUIREMENT & SUPPLY/ SOURCE .......................................................... 30

7 REHABILITATION AND RESETTLEMENTS (R& R) PLAN ................................... 31

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 5

7.1 POLICY TO BE ADOPTED (CENTRAL/STATE) IN RESPECT OF THE PROJECT AFFECTED PERSONS INCLUDING

HOME OUSTEES, LAND OUSTEES AND LANDLESS LABOURERS (A BRIEF OUTLINE TO BE GIVEN) ......... 31

8 PROJECT SCHEDULE AND COST ESTIMATE .................................................... 32

8.1 LIKELY DATE OF START OF CONSTRUCTION AND LIKELY DATA OF COMPLETION (TIME SCHEDULE FOR THE

PROJECT TO BE GIVEN) ......................................................................................... 32

8.2 ESTIMATED PROJECT COST ALONG WITH ANALYSIS IN TERMS OF ECONOMIC VIABILITY OF THE PROJECT.

32

9 ANALYSIS OF PROPOSAL ........................................................................... 33

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 6

1 EXECUTIVE SUMMARY

1.1 Plant Features and Production Capacity

Richmond Research & Pharmaceuticals LLP, (RRPL) limited Liability Partnership firm is proposing

industrial unit for pharmaceutical products at Survey no. 137 Village Govindpura, Taluka Kadi, District

Mehsana-382170. RRPL is proposing API & Intermediate pharmaceutical products with total

investment of rs. 2.80 crores including land, plant & machineries and building required for the project.

The said products are synthetic organic chemical products to be manufactured through organic

chemical reactions.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 7

2 INTRODUCTION

2.1 Identification for Project Proponent & Proposed Project

2.1.1 Project Proponent

The project proponents are qualified in Pharmacy having experience of industrial manufacturing activities as

well as academic experience in Pharmacy Collage.

2.1.2 Proposed Project

Proposed project is Greenfield project for manufacturing of API & Intermediate pharmaceutical products.

Land admeasuring 2,681.00 m2 is already acquired which includes Survey No: 137, Village Govindpura, Taluka

Kadi, District Mehsana, and Gujarat.

2.2 Brief Description of the Project

Proposed project is Greenfield project for manufacturing of pharma bulk drug & pharma intermediate in

Survey No: 137, Village Govindpura, Taluka Kadi, District Mehsana, Gujarat.

2.3 Need for the project and it’s importance to region

In the last few decades, India’s population is increasing and so is the demand for Drugs to support this

population. In order to satisfy this need, more production of bulk drugs and active pharma ingredients is

needed. The company will bring new job opportunities for the local people. They will, therefore, become

economically stronger.

2.4 Demand Supply Gap

The demand for APIs and API intermediates is a derived demand. It gets derived from the demand for various

medicinal formulations (final administrable drugs) for the formulation industry.

The APIs and API intermediates being manufactured by basic drug manufacturers are exported as such or

used by domestic formulators in their production processes. The formulation firms further produce final

medicines and export these as well as sell these in the domestic market.

There is a wide gap in the demand and availability of cheap and quality medicines in India and the world

over.

2.5 Import vs. Indigenous Production

The proposed manufacturing products in the country will be very much viable & acceptable compare to

imports due to market abased research, updated technology, Experienced & Qualified partners, manpower,

quality & Services for products.

2.6 Export Possibility

The pharma products market has fast progressing and there is ample opportunity in indigenous as well as

export market.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 8

2.7 Employment Generation (Direct and Indirect) due to the project.

During the construction phase around 20 workers will be hired. During operation phase, project will generate

direct employment for more than 25 people for the proposed unit.

Local skilled and semi-skilled workers will be engaged during construction phase. The positive impact include

enhanced direct employment for technical/administrative works and indirect employment. The activities under

proposed project will have positive impact on the socio economic status of people in the study area in terms

of local labor employment & contract basis jobs. The proposed activity will provide employment opportunities

to the local populace, especially in business and other services like transportation activity.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 9

3 PROJECT DESCRIPTION

3.1 Type of Project

Proposed project is Greenfield project for manufacturing of pharma bulk drug & pharma intermediate in

Survey No: 137, Village Govindpura, Taluka Kadi, District Mehsana, and Gujarat.

3.2 Location (map showing general location, specific location and project boundary &

project lay out) with coordinates

The unit is located at Survey No. 137, village Govindpura, Taluka Kadi, District Mehsana, and Gujarat. Land

document is attached as Anenxure-1.

Location map showing general location of proposed project is given in Figure 3-1. Specific map showing

project boundary is given in Figure 3-2.

Figure 3-1: General Location Map of Proposed Project

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 10

Figure 3-2: Specific Location map showing project boundary

3.3 Details of alternate sites considered and the basis of selecting the proposed

site, particularly the environmental considerations gone into should be highlighted

The proposed site is connected with Town Sanand and Sanand Industrial Area.

Potential development area for industrial sector.

Cost effective land availability

Considering above facts, we are proposing the product Mix at said location.

3.4 Size or Magnitude of Operation

Plot area of the project consists of 2,681 m2. Details of all the proposed products are listed in Table 3-1.

Table 3-1: Production Capacity

Sr. No.

Name of the Products CAS no. /CI no. Quantity MT/Month End-use of products

1 Chlorhexidine Base 55-56-1 12.50 Disinfectant and antiseptic

2 Chlorhexidine

Digluconate 18472-51-0 2.08 Disinfectant and antiseptic

3 Chlorhexidine Diacetate 56-95-1 2.08 Disinfectant and antiseptic

4 Chlorhexidine

Hydrochloride 3697-42-5 2.08 Disinfectant and antiseptic

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 11

Sr. No.

Name of the Products CAS no. /CI no. Quantity MT/Month End-use of products

5 Trimethyl sulfoxonium

Iodide 1774-47-6

2.50 Pharmaceutical intermediate

6 Methyl Iodide 74-88-4 2.08 Pharmaceutical intermediate

7

Sildenafile citrate 171599-83-0

0.83

To treat erectile dysfunction and

pulmon ary arterial hypertension

8 Celecoxib 169590-42-5 0.83 Non-steroidal anti- inflammatory

drug

Raw Material consumption for each product is given in Table 3-2.

Table 3-2: Raw Material Consumption

Sr. no.

Name of the Products Name of the Raw Materials CAS / CI no. of raw

materials. Quantity MT/Month

1 Chlorhexidine Base

Hexamethylene diamine 124-09-4 4.73

Sodium dicynamide 1934-75-4 7.20

p-Chloroaniline HCL 20265-96-7 14.20

Butanol 71-36-3 145.45

Hydrochloric acid 7647-01-0 13.64

Sodium Hydroxide 1310-73-2 4.32

Water 7732-18-5 56.82

Methanol 67-56-1 59.85

Hyflo 61790-53-2 0.23

Triethyl amine 121-44-8 1.70

2 Chlorhexidine Digluconate

Chlorhexidine Base 55-56-1 1.25

Gluconic acid 526-95-4 0.98

Water 7732-18-5 7.31

Carbon 7440-44-0 0.02

3 Chlorhexidine Diacetate

Chlorhexidine Base 55-56-1 1.77

Acetic acid 64-19-7 0.46

Water 7732-18-5 4.48

Carbon 7440-44-0 0.02

4 Chlorhexidine Hydrochloride

Chlorhexidine Base 55-56-1 1.90

30% HCL 7647-01-0 0.31

Water 7732-18-5 3.25

Carbon 7440-44-0 0.02

5 Trimethyl sulfoxonium

Iodide

Methyl iodide 74-88-4 1.55

Dimethyl sulfoxide 67-68-5 1.54

Methanol 67-56-1 1.83

6 Methyl Iodide

Potassium iodide 7681-11-0 2.87

Dimethyl sulphate 77-78-1 1.53

Water 7732-18-5 8.60

7 Sidenafil citrate

Sidenafil Base 139755-83-2 0.61

Citric acid 77-92-9 0.25

Water 7732-18-5 2.50

8 Celecoxib Dione 720-94-5 0.83

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 12

Sr. no.

Name of the Products Name of the Raw Materials CAS / CI no. of raw

materials. Quantity MT/Month

Sulphonamide 63-74-1 1.25

Acetic acid 64-19-7 1.83

Toluene 108-88-3 11.67

Carbon 7440-44-0 0.10

Water 7732-18-5 18.33

IPA 67-63-0 2.17

3.5 Technology and Process Description

3.5.1 Manufacturing process for Chlorhexidine base:

Reactions take place between Hexmethyl diamine and hydrogen chloride and produce. Hexamethyl diamine hydrochloride salt. This salt is further reacts with sodium dicynamide followed by p-chloroanilin and produce Chlorhexidine acid. Which is neutralize by sodium hydroxide followed by isolation of chlorohexidine base final pH of 7.0 and water is added. Finally the liquid is packed in a drum as a final product.

Chemical Reaction:

HCl NaN(CN) 2

H2N(CH2)6NH2 HClH2N(CH2) 6NH2.HCl

n-Butanol n-Butanol

triethylamine

NCNHC(=NH)NH(CH2)6NHC(=NH)NHCN

Hexamethyllene bisdicyanamide

NH2.HCl

Cl

p-chloroaniline hydrochloride NaOH

NH(HN=)CHN(HN=)CHN(CH2)6NHC(=NH)NHC(=NH)NH

Cl Cl

CHLORHEXIDINE

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 13

Flow diagram :

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 14

Mass Balance : Per day quantity

Input (Kg) Output (Kg)

Hexamethylene diamine 0.38 Product 1.00

Sodium dicynamide 0.58 Rec Butanol 10.47

p-Chloroaniline HCl 1.14 Butanol loss 1.16

Butanol 11.64 Rec Methanol 4.31

Hydrochloric acid 1.09 Methanol loss 0.48

Sodium Hydroxide 0.35 Residue 0.41

Water 4.55 Effluent 6.82

Methanol 4.79 Hyflo 0.02 Triethyl amine 0.14 Total 24.65 Total 24.65

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 15

3.5.2 Manufacturing process for chlorhexidine digluconate:

Chlorhexidine base will react with gluconic acid and produce Chlorhexidine digluconate. Carbon

treatment is required for color improvement followed by filtration and drying.

Chemical Reaction :

C22H30Cl2N10 + 2 (C6H12O7) C22H30Cl2N10. 2(C6H12O7)

Chlorhexidine Gluconic acid Chlorhexidine digluconate

Flow Diagram :

Mass Balance :

Input (Kg) Output (Kg)

Chlorhexidine Base 0.60 Product 1.00

Gluconic acid 0.47 Mother liquor 3.37

Water 3.51 Water Loss 0.20

Carbon 0.01 Spent carbon 0.02

Total 4.59 Total 4.59

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 16

3.5.3 Manufacturing process for chlorhexidine diacetate:

Chlorhexidine base will react with acetic acid and produce Chlorhexidine diacetate. Carbon treatment

is required for color improvement followed by filtration and drying.

Chemical Reaction :

C22H30Cl2N10 + 2 (C2H4O2) C22H30Cl2N10. 2(C2H4O2)

Chlorhexidine Acetic acid Chlorhexidine diacetate

Flow Diagram :

Mass Balance :

Input (Kg) Output (Kg)

Chlorhexidine Base 0.85 Product 1.00

Acetic acid 0.22 Mother liquor 2.01

Water 2.15 Water Loss 0.20

Carbon 0.01 Spent carbon 0.02

Total 3.23 Total 3.23

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 17

3.5.4 Manufacturing process for chlorhexidine dihydrochloride:

Chlorhexidine base will react with Hydrochloric acid and produce Chlorhexidine diacetate. Carbon

treatment is required for color improvement followed by filtration and drying.

Chemical Reaction :

C22H30Cl2N10 + 2 H C l C22H30Cl2N10. 2(C2H4O2)

Chlorhexidine Hydrochloric acid Chlorhexidine dihydrochloride

Flow Diagram :

Mass Balance :

Input (Kg) Output (Kg)

Chlorhexidine Base 0.91 Product 1.00

30% HCl 0.15 Mother liquor 1.33

Water 1.56 Water Loss 0.20

Carbon 0.01 Spent carbon 0.02

Total 2.63 Total 2.55

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 11

3.5.5 Manufacturing process for Trimethyl sulfoxonium iodide:

Dimethyl sulfoxide is reacts with methyl iodide at elevated temperature and produce trimethyl

sulfoxonium iodide. It is isolated by filtration followed by drying.

Chemical Reaction :

Flow Diagram:

Mass Balance :

Input (Kg) Output (Kg)

Methyl iodide 0.62 Product 1.00

Dimethyl sulfoxide 0.61 Rec methanol 0.70

Methanol 0.73 Effluent 0.27

Methanol loss 0.03

Total 1.97 Total 1.97

e

H3C I +

O

S

O

S

+ I-

H3C CH3 H3C CH

CH3

3

Methyl Iodide

M.W. 142

Dimethyl sulfoxide

M.W. 78

Trimethyl sulfoxonium iodid

M.W. 220

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 12

3.5.6 Manufacturing process for Methyl iodide:

Methyl iodide is prepared by reaction between potassium iodide and dimethyl sulfate. Product

is collected by distillation.

Chemical Reaction :

Flow Diagram :

Mass Balance :

Input (Kg) Output (Kg)

Potassium iodide 1.38 Product 1.00

Dimethyl sulfate 0.73 Effluent 5.24

Water 4.13 Total 6.24 Total 6.24

2 K I + H3C O

S H3C O

O

2 H3C I + K

O

O

S

O K O O

Potassium Iodide

M.W. 166

Dimethyl Sulfate

M.W. 126

Methyl iodide Potassium sulfate

M.W. 142 M.W. 174

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 13

3.5.7 Manufacturing process for sildenafil citrate:

Sildenafil base is reacts with citric acid in presence of water and produce sildenafil citrate. Isolation is

performed by filtration followed by drying.

Chemical Reaction :

Flow Diagram :

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 14

N

N

Mass Balance:

Input (Kg) Output (Kg)

Sildenafil Base 0.73 Product 1.00

Citric acid 0.30 Mother liquor 2.90

Water 3.00 Water Loss 0.13

Total 4.03 Total 4.03

3.5.8 Manufacturing process for celecoxib:

Methyacetophenone is condensed with isopropyl tri-fluoroacetate to give 4,4,4-Trifluoro-1- (4-

methylphenyl) butane-1, 3-dione, which is cyclised with 4-hydrizin-ophenyl sulphonamide to give

Celecoxib.

Chemical Reaction :

SO 2NH 2

O O

CF3 +

SO2NH2

acetic acid

H3C

90 to 110°C

H3C

NHNH 2 HCl

Dione Sulphonamide Celecoxib

CF3

Molecular Formula = C11H9F3O2

Molecular Formula = C6H10ClN3O2S Molecular Formula = C17H14F3N3O2S

Formula Weight = 230.1831696 Formula Weight = 223.6805 Formula Weight = 381.3721696

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 15

Flow Diagram :

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 16

Mass Balance :

Input (Kg) Output (Kg)

Dione 1.00 Product 1.00

Sulphonamide 1.50 Rec Toluene 12.90

Acetic acid 2.20 Spent carbon 0.12

Toluene 14.00 Waste water 24.60

Carbon 0.12 Residue 1.10

Water 22.00 Toluene loss 1.10

IPA 2.60 IPA recovery 2.35

IPA loss 0.25

Total 43.42 Total 43.42

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 17

3.6 Raw Materials

Details of raw material requirement along with estimated quantity, likely source, marketing area of

final products, mode of transport of raw material and finish product are given in Table 3-3

Table 3-3: Raw Material Details

Sr. Name of the Products

Name of the Raw Materials

CAS / CI no. of raw materials.

Quantity MT/Month

State Storage Transportation no.

1 Chlorhexidine

Base

Hexamethylene diamine

124-09-4 4.73 Solid Drum By Road

Sodium dicynamide

1934-75-4 7.2 Solid Bag By Road

p-Chloroaniline HCL

20265-96-7 14.2 Solid Bag By Road

Butanol 71-36-3 145.45 Liquid Drum By Road

Hydrochloric acid 7647-01-0 13.64 Liquid Drum By Road

Sodium Hydroxide

1310-73-2 4.32 Solid Bag By Road

Water 7732-18-5 56.82 Liquid Water Tank ---

Methanol 67-56-1 59.85 Liquid Drum By Road

Hyflo 61790-53-2 0.23 Solid Bag By Road

Triethyl amine 121-44-8 1.7 Liquid Drum By Road

2 Chlorhexidine Digluconate

Chlorhexidine Base

55-56-1 1.25 Solid Bag By Road

Gluconic acid 526-95-4 0.98 Solid Bag By Road

Water 7732-18-5 7.31 Liquid Water Tank ---

Carbon 7440-44-0 0.02 Solid Bag By Road

3 Chlorhexidine

Diacetate

Chlorhexidine Base

55-56-1 1.77 Solid Bag By Road

Acetic acid 64-19-7 0.46 Liquid Drum By Road

Water 7732-18-5 4.48 Liquid Water Tank ---

Carbon 7440-44-0 0.02 Solid Bag By Road

4 Chlorhexidine Hydrochloride

Chlorhexidine Base

55-56-1 1.9 Solid Bag By Road

30% HCL 7647-01-0 0.31 Liquid Drum By Road

Water 7732-18-5 3.25 Liquid Water Tank ---

Carbon 7440-44-0 0.02 Solid Bag By Road

5 Trimethyl

sulfoxonium Iodide

Methyl iodide 74-88-4 1.55 Liquid Aliminium Contained

By Road

Dimethyl sulfoxide

67-68-5 1.54 Liquid Drum By Road

Methanol 67-56-1 1.83 Liquid Drum By Road

6 Methyl Iodide

Potassium iodide 7681-11-0 2.87 Solid Bag By Road

Dimethyl sulphate 77-78-1 1.53 Liquid Drum By Road

Water 7732-18-5 8.6 Liquid Water Tank ---

7 Sidenafil citrate

Sidenafil Base 139755-83-2 0.61 Solid Bag By Road

Citric acid 77-92-9 0.25 Solid Bag By Road

Water 7732-18-5 2.5 Liquid Water Tank ---

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 18

Sr. Name of the Products

Name of the Raw Materials

CAS / CI no. of raw materials.

Quantity MT/Month

State Storage Transportation no.

8 Celecoxib

Dione 720-94-5 0.83 Solid Bag By Road

Sulphonamide 63-74-1 1.25 Solid Bag By Road

Acetic acid 64-19-7 1.83 Liquid Drum By Road

Toluene 108-88-3 11.67 Liquid Drum By Road

Carbon 7440-44-0 0.1 Solid Bag By Road

Water 7732-18-5 18.33 Liquid Water Tank ---

IPA 67-63-0 2.17 Liquid Drum By Road

3.7 Process Description

Manufacturing process is provided in Section 3.5 of Chapter 3.

3.8 Additives and Chemicals

Given in Section 3.6

3.9 Raw material required along with estimated quantity, likely source,

marketing area of final products, mode of transport of raw material and

finished product.

Transportation details of Raw Materials given in Section 3.6 of Chapter 3.

3.10 Availability of water its source, energy/power requirement and source

should be given

3.10.1 Power Requirement

Power requirement will be full filled by Uttar Gujarat Vij Company Ltd. (UGVCL), Mehsana. DG set

of 125 kVA will be installed for emergency purpose.

3.10.2 Water consumption

Source of water: Ground Water

Table 3-4: Water Consumption

No. Particulars Fresh water Recycled Treated

Effluent Total water requirement

1 Domestic 2.00 1.00 3.00

2 Industrial

A Process 3.00 0.00 3.00

B Floor / container / Equipment Washing 0.00 0.38 0.38

C Scrubbing 0.00 2.00 2.00

D Boiler & Cooling 6.98 3.82 10.80

E RO Reject 3.00 0.00 4.00

Sub-Total Industrial Use 12.98 6.20 19.18

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 19

3 Gardening & Misc. 3.00 0.00 3.00

Total Requirement 17.98 7.20 25.18

3.10.3 Fuel

Proposed: Bio Coal (1.2 MT/Day) OR Imported Coal (2 MT/Day)

3.11 Quantity of waste to be generated (liquid and solid) and scheme for their

management /disposal

Environmental issues associated with pharma bulk drug & pharma intermediate manufacturing

units include:

Air Emissions;

Wastewater;

Solid Waste.

3.11.1 Air Emissions

Details of gaseous emissions from process and flue gas stacks and attached air pollution

equipment are given in Table 3-5 & Table 3-6

Table 3-5: Details of stacks, fuel used & APCM attached to flue gas stacks

Sr. No Boiler Fuel Consumption Stack

Height in m APCM

1 IBR Boiler

Bio Coal (Briquettes)

OR

Imported Coal

1.2 MT/Day

OR

2 MT/Day

11 Multi Cyclone Dust

Collector

2 DG Set

(125 KVA) Diesel 60 ltr/hr 7.5 Adequate Stack Height

Table 3-6: Details of stacks, APCM attached to Process Gas Stacks

Sr. No.

Stack Attached to Nos. of stacks

Stack Height (m)

Pollutant Emitted

Air Pollution Control Measures attached

1 Heating in Reaction

Vessel 1 11 HCl Two stage alkali scrubber

2 Centrifuge, Dryer 1 11 Dust Particles Auto-Reverse Pulse Jet

Bag Filter

3.11.2 Wastewater Generation

Table 3-7: Waste Water Generation

No. Particulars Wastewater generation in KL/D

1 Domestic 2.70

2 Industrial

A Process 3.90

B Floor / container / Equipment Washing 0.38

C Scrubbing 2.00

D Boiler & Cooling 1.20

E RO Reject 3.00

Sub-Total Industrial Use 10.48

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 20

3 Gardening & Misc. -

Total generation 13.18

3.11.3 Hazardous waste Generation and Disposal Details

Details of hazardous waste generation, storage and disposal details are given in Table 3-8.

Table 3-8: Hazardous Waste Generation and disposal Details

S.

No. Type of Waste

Hazardous Waste

Category

Quantity in

MT/Annum

Treatment /

Disposal

1 ETP Sludge 34.3 5 To Authorized TSDF

site

2 Spent Oil 5.1 0.1 To MOEF approved

vendors

3 Discarded Containers /

Liners/ Barrels 33.3 5

To GPCB approved vendors

4 Process Residue & waste 28.1 5 To Common

Incineration Facility

5 Spent Catalysts 28.2 5 Authorized Recyclers

6 Spent Carbon 28.3 5 Authorized Recyclers

7 Off-Specification Products 28.4 5 To Authorized TSDF

site

3.12 Wastewater Treatment facility

The Sewage will be treated and disposed of through Septic Tank and Soak Well. The Industrial Waste water

generated will be segregated based on organic and inorganic contents. The organic content wastewater

generated from process (high concentrated stream) and washings (low concentrated stream) will be collected

in organic effluent sump. The organic stream will be neutralized, get settled solids in two another sumps. The

neutralized organic effluent will be transferred to final organic effluent sump and will be sent to Authorized

Common Incineration Facility. The sludge from the bottom of the sump will be collected once in 1 to 6

months and will be dried, bagged & stored in ETP Sludge storage yard. The ETP sludge will be sent to

Authorized TSDF site.

The inorganic effluent from Cooling tower, Boiler, Scrubber and RO Reject will be collected in Inorganic

Effluent Sump. The pH will be corrected and solid liquid separation will be carried out in settling tank. The

clear effluent will be collected in the Inorganic Intermediate Storage Sump. The pre- Treatment will be

provided including PSF, ACF followed with UF or MF to feed to Two Stage RO. The permeate will be recycled

in the make up for Cooling, Boiler and Scrubber. The reject effluent will be charged to MEE / Thermal

Evaporator.

The sludge will be collected, bagged and stored in ETP Storage yard. The Sludge will be sent to Authorized

TSDF site.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 21

4 SITE ANALYSIS

4.1 Connectivity

4.1.1 By Road

The site is well connected to Sanand City via NH-08 at an aerial distance of ~14.70 km in SE

Direction.

4.1.2 By Rail

The nearest major railway station from project site is Sabarmati Railway Station which is located

at an aerial distance of ~28.79 km in ESE Direction.

4.1.3 By Air

The nearest airport from the project site is Ahmedabad Airport located at an aerial distance of ~

31.92 km in ESE direction.

4.2 Land Form, Land Use and Land ownership

The land is in the form of industrial land owned by the RRPL. The total plot area 2,681 m2 is

belonging to Richmond Research & Pharmaceuticals LLP. Land Possession Document is attached

as Annexure 1.

4.3 Topography (along with map)

Toposheet of proposed project is given in Map 4-1.

RICHMOND RESEARCH & PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL PRODUCTS AT VILL. GOVINDPURA,

TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 22

Map 4-1: Toposheet

RICHMOND RESEARCH &

PHARMACEUTICALS LLP

PFR FOR PROPOSED API & INTERMEDIATE

PHARMACEUTICAL PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 23

4.4 Existing land use pattern (agriculture, non-agriculture, forest, water

bodies (including area under CRZ)), shortest distances from the periphery

of the project to periphery of the forests, national park, wild life

sanctuary, etc sensitive areas, water bodies (distance from the HFL of the

river), CRZ. In case of notified industrial area, a copy of the Gazette

notification should be given.

Land use pattern: proposed project will be carried out in Non-Agricultural approve industrial land,

located at survey no.137, village Govindpura, Taluka Kadi, District Mehsana which has available

infrastructure like water, electricity, roads, rail and transportation facility. Surrounding area is

consisting with agriculture, infrastructure and other industrial units. The nearest habitation located

within 10 km radius of the project site are listed in __

Table 4-1: Nearest Habitation

Sr. No. District Sub- district Distance (Kms) Habitation HH Population

1 Mehssana Kadi 0-3 km Khanderavpura 325 1283

2 Mehssana Kadi 0-3 km Nadan 260 1427

3 Mehssana Kadi 0-3 km Govindpura 157 612

4 Ahmedabad Sanand 0-3 km Anadej 838 4408

Sub- Total 1580 7730

5 Mehssana Kadi 3-5km Kanjari 324 1622

6 Mehssana Kadi 3-5km Medha 338 1420

7 Mehssana Kadi 3-5km Chandrasan 444 2240

8 Mehssana Kadi 3-5km Yashvantpura 170 631

9 Ahmedabad Sanand 3-5km Rampura 107 459

10 Ahmedabad Sanand 3-5km Bhavanpur 217 1087

11 Ahmedabad Sanand 3-5km Dodar 487 2421

12 Ahmedabad Sanand 3-5km Sakalpur 0 0

Sub Total 2,087 9,880

13 Gandhinagar Kalol 5-7 km Mulasana 226 1172

14 Ahmedabad Sanand 5-7 km Iyava 514 2525

15 Ahmedabad Sanand 5-7 km Chharodi 512 2655

16 Mehssana Kadi 5-7 km Panthoda 469 2401

17 Mehssana Kadi 5-7 km Agol 947 4502

18 Mehssana Kadi 5-7 km Chandanpura 0 0

19 Mehssana Kadi 5-7 km Viramgampura 0 0

20 Mehssana Kadi 5-7 km Virpara 0 0

Sub Total 2,668 13,255

21 Mehssana Kadi 7-10 Km Lakshmanpura 301 1299

22 Mehssana Kadi 7-10 Km Bavlu 799 3869

23 Mehssana Kadi 7-10 Km Jhaloda 547 2973

24 Mehssana Kadi 7-10 Km Thol 1415 6866

25 Mehssana Kadi 7-10 Km Jesangpura 213 841

26 Mehssana Kadi 7-10 Km Della 266 1322

RICHMOND RESEARCH &

PHARMACEUTICALS LLP

PFR FOR PROPOSED API & INTERMEDIATE

PHARMACEUTICAL PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 24

Sr. No. District Sub- district Distance (Kms) Habitation HH Population

27 Mehssana Kadi 7-10 Km Jamiyatpura 101 577

28 Mehssana Kadi 7-10 Km Vinayakpura 110 434

29 Mehssana Kadi 7-10 Km Nanpurasonvad 148 636

30 Mehssana Kadi 7-10 Km Kolad 328 1604

31 Gandhinagar Kalol 7-10 Km Adhana 106 581

32 Gandhinagar Kalol 7-10 Km Vayana 294 1456

33 Gandhinagar Kalol 7-10 Km Vansajada Dhedia 288 1490

34 Ahmedabad Sanand 7-10 Km Chekhla 924 4774

35 Ahmedabad Sanand 7-10 Km Vasna Iyava 571 2624

36 Ahmedabad Sanand 7-10 Km Khoda 360 1929

37 Ahmedabad Sanand 7-10 Km Kalana 411 2003

38 Ahmedabad Sanand 7-10 Km Virochannagar 1371 7081

Sub Total 8553 42359

Grand Total 14,888 73,224

Source: Census Data 2011

Table 4-2: Distance of Project Site from Sensitive Areas

Area Distance in km Direction

Sabarmati River ~28 km ESE

Thol Bird Sanctuary ~10.13 km ENE

SH-17 ~7.74 km S

NH-8(a) ~22.73 SE

Ahmedabad ~21.98 ESE

Nearest Industries

Nearest Industrial Area is Sanand GIDC which is located at an aerial distance of ~7.0 km in S

Direction.

4.5 Soil classification

General soil classification of the area is as under:

Slight to Moderate sodicity is found in central part of the region in Mehsana District. Major Soil

type is sandy soil in the district. Kyari soils are found in several parts of area. It is the most fertile

soil with very good moisture and retentive.

4.6 Climatic data from secondary sources

Secondary Data Collection and Review

Secondary data for weather conditions in the region is available from long-term climatological

tables attached as an __(on page no. Error! Bookmark not defined.) For 30 years i.e. from 1981-

2010, published by Indian meteorological department. Ahmedabad_42647 is the nearest IMD

RICHMOND RESEARCH &

PHARMACEUTICALS LLP

PFR FOR PROPOSED API & INTERMEDIATE

PHARMACEUTICAL PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 25

station from proposed project site located at an aerial distance of ~21.98 km towards ESE

direction.

The seasons are post monsoon (which includes the months of October, November), winter (which

includes the months of December, January and February) and summer (which includes March,

April and May).

Long-term climatological data analyzed / reviewed for important parameters like temperature,

humidity, wind speed, wind direction, cloud cover and rainfall. The findings are:

Temperature

In the post monsoon, mean daily maximum temperature was recorded between 32.9 – 35.7 °C.

The extreme highest 42.8 °C was recorded on 5th October, 1920. Mean daily minimum

temperature was recorded between 16.7 – 21.4 °C. The extreme lowest 8.3 °C was recorded on

29th November, 1975.

In winter season, mean daily maximum temperature was recorded between 28.1 – 30.8 °C. The

extreme highest 40.6 °C was recorded on 28th February 1953. Mean daily minimum temperature

was recorded between 12.4-14.3 °C. The extreme lowest 2.2 °C was recorded on 6th February,

1920.

In summer season, mean daily maximum temperature was recorded between 35.8 –41.6 °C. The

extreme highest 47.8 °C was recorded on 27th May 1916. Mean daily minimum temperature was

recorded between 19.5 – 27 °C. The extreme lowest 9.4 °C was recorded on 2nd March, 1982.

Humidity

In post monsoon season humidity in morning hours ranges between 57 – 65% while in evening

hours it was between 36 – 41%.

In winter season humidity in morning hours ranges between 56 – 61% while in evening hours it

was between 26 – 37%.

In summer humidity in morning hours ranges between 50 – 65% while in evening hours it was

between 20 – 25%. Summer is hot and humid.

Highest humidity levels observed during June – Sept months which is period of active monsoon

season. Humidity in morning hours remains between 74 – 87% and in evening hours it was

remains between 44 – 72%.

Wind Speed

During the study period, i.e. February - April, first predominant wind direction is from NW direction

(31.3 %), second predominant wind direction is from W Direction (17.5%) and third

predominant wind direction is from N Direction (12%). Calm condition contributes to 14.5%.

Wind Direction

Table 4-3: Wind regime as per IMD long-term Data – Ahmedabad Station

Month

Predominant Wind

First Second Third

Morning Evening Morning Evening Morning Evening

January NE N E NW N NE

February NE,NW NW E N N NE

March NW NW W W E N

RICHMOND RESEARCH &

PHARMACEUTICALS LLP

PFR FOR PROPOSED API & INTERMEDIATE

PHARMACEUTICAL PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 26

Month

Predominant Wind

First Second Third

Morning Evening Morning Evening Morning Evening

April NW W W NW SW SW

May SW W W SW NW NW

June SW SW W S S W

July SW SW S,W S NW W

August SW SW W W S S

September W SW,W NW NW SW S

October E,NW N N,NE NW W E

November NE,E N N E NW NE

December NE N E NE NW NW

Cloud Cover

The area remains cloudy between June - September, which is the active period of the monsoon

season. Generally cloud cover ranges from 4 to 6.6 OKTAS during this monsoon season.

In the winter season, cloud cover ranges from 1.2 to 1.6 OKTAS.

Rainfall

The distribution of rainfall in the region, which includes the study area, is regular. Annual total

rainfall in the region is 750.9 mm.

Distribution of rainfall by season is 724.2 mm in monsoons (June, July, August, September), 14

mm in post-monsoons (October – November), 2.8 mm in winter (December, January, February)

and 10.0 mm in summer (March, April, May). About 96.4 percent of the annual rainfall in the

region is received during the monsoon months i.e. June to September. July is the rainiest month.

July is the rainiest month having maximum number of rainy days as 11.5. Heaviest rainfall in 24

hours was recorded as 414.8 mm on 27th July, 1927

4.7 Social infrastructure available

Local conveyance and links due to State highway and National Highway, the stack holders are

conveniently commute to works from residents. Ahmedabad is metro city located near to the site

and surrounding area is majorly agriculture, residential and commercial areas, with agriculture

practices. Post-monsoon, the workers/labors presence are affected due to agriculture practice in

surrounding areas.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP

PFR FOR PROPOSED API & INTERMEDIATE

PHARMACEUTICAL PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 27

5 PLANNING BRIEF

5.1 Planning Concept

The area is near to industrial area of Sanand Auto Sector engaged in manufacture of variety of

products. Area has available infrastructure like water, electricity, roads, rail, and transportation,

availability of raw material, CETP, TSDF and CMEE system.

5.2 Population Projection

Refer Chapter 2, Section 2.5

5.3 Land use Pattern

The total plot area of survey n. 137 is 2,681 m2. Details of land use and green belt will be as per

site layout map. Tentative area statement is given in Table 5-1.

Table 5-1: Area Statement

Sr. No. Area Statement Area( m2) % of Total Area

1 Production area 125 4.7

2 Raw material and product storage area 75 2.8

3 Administrative Office and Laboratory 50 1.9

4 Utilities 200 7.5

5 Greenbelt 900 33.6

6 Road and Open Area 1,331 49.6

Total 2,681 100.0

5.4 Assessment of Infrastructure Demand (Physical & Social)

Key infrastructure such as hospitals, schools, bank, places of worship and social/ community

facilities such as park, market, playground etc. education, health care, community development,

income distribution, employment and social welfare are available in nearby areas of Govindpura

village, Kadi Village and other major villages in the area as well as in Ahmedabad City.

5.5 Amenities/Facilities

5.5.1 Education:

Schools including Primary and middle schools, social welfare hostels are established within

surrounding area.

5.5.2 Medical & Health

Ultra-modern and Specialty Treatment Hospitals, General Hospitals (including Government and

Private), Community Health Centre & Primary Health Center are available nearby area.

5.5.3 Power & Water

Unit is connected with power supply from UGVCL. The ground water is available within the

surrounding area and the small canal is passing through the surrounding area.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP

PFR FOR PROPOSED API & INTERMEDIATE

PHARMACEUTICAL PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA TABLE OF CONTENT

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 28

5.5.4 Rail and Road

The project site is very well connected by road through State Highway and Western railways.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA CHAPTER NAME

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 29

6 PROPOSED INFRASTRUCTURE

6.1 Industrial Area (processing area)

Basic Infrastructure will be developed and the required additional plant and machineries will be

installed after getting statutory clearance.

6.2 Residential Area (non-processing area)

No residential area is involved in the core area of proposed project. The employs are accommodated

in nearby Residential Areas.

6.3 Green belt

33.6 % of total plot area will be developed as greenbelt.

6.4 Social Infrastructure

6.5 Connectivity (Traffic and transportation road/ rail/metro/water ways etc).

Refer Chapter 4, Section 4.1.

6.6 Drinking water management (source & supply of water)

Water requirement will be full filled through Ground Water Supply.

6.7 Sewage system

Sewage is disposed off to soak pit through septic tank.

6.8 Industrial waste management

The Sewage will be treated and disposed of through Septic Tank and Soak Well.

The Industrial Waste water generated will be segregated based on organic and inorganic contents.

The effluent will be neutralized, get settled solids in two another sumps. The neutralized effluent will

be transferred to final effluent sump and will be sent to recycling RO followed by MEE. The RO

permeate will be recycled in the make up for Cooling, Boiler and Scrubber. The RO reject effluent will

be charged to MEE / Thermal Evaporator.

The sludge will be collected, bagged and stored in ETP Storage yard. The Sludge will be sent to

Authorized TSDF site.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA CHAPTER NAME

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 30

6.9 Solid waste management

Please Refer Section 3.11.3 of Chapter-3.

6.10 Power requirement & supply/ source

Uttar Gujarat Vij Co. Ltd. for demand of 140 KW for proposed project. For emergency purpose, DG set

of 125 kVA will be installed.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA CHAPTER NAME

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 31

7 REHABILITATION AND RESETTLEMENTS (R& R) PLAN

7.1 Policy to be adopted (central/state) in respect of the project affected

persons including home oustees, land oustees and landless labourers

(a brief outline to be given)

R & R Plan is not applicable.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA PROJECT SCHEDULE &

COST ESTIMATE

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 32

8 PROJECT SCHEDULE AND COST ESTIMATE

8.1 Likely date of start of construction and likely data of completion (time

schedule for the project to be given)

After obtaining Environmental Clearance and amendment of Consent to Establish from GPDB, the

company shall start the proposed construction and commissioning of the project.

8.2 Estimated project cost along with analysis in terms of economic viability of

the project.

Estimated project cost would be Rs. 2.8 Crore. Breakup of the project cost is given in Table 8-1.

Table 8-1: Estimated Project Cost

Sr. No. Purpose Cost (Lakhs.)

1 Land & Building 140

2 Plant & Machinery 130

3 Environmental Management System and Plan 10

Total 280

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA ANALYSIS OF PROPOSAL

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 33

9 ANALYSIS OF PROPOSAL

Project will create revenue expected from royalty, taxes, duties and other fees to the state as well as

to the central government and will attract the direct & indirect employment opportunities. Unit will use

good faith efforts to employ local people from the nearby villages depending upon the requirement

and availability of skilled & un-skilled man-power. An added benefit to the proposed project will result

in considerable growth of stimulating the industrial and commercial activities in the state.

The process and activities related to the project applied are not diminishing the objectives of

development in the surrounding. The project proponent team is qualified and experienced for such

product manufacturing, are confident of the project launching in the said location. The project will

have the products those are clean in process and will not create the negative impact on the

surrounding environment and hence, we propose for the approval.

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA ANNEXURES

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 34

Annexures

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA ANNEXURES

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 35

Annexure 1: Land Possession Document

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA ANNEXURES

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 36

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA ANNEXURES

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 37

RICHMOND RESEARCH &

PHARMACEUTICALS LLP PFR FOR PROPOSED API & INTERMEDIATE PHARMACEUTICAL

PRODUCTS AT VILL. GOVINDPURA, TA. KADI, DIS. MEHSANA ANNEXURES

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 38

CLIENT NAME PROJECT NAME CHAPTER NAME

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 39

Annexure 2: Long Term Meteorological Data of Ahmedabad (42642)

CLIENT NAME PROJECT NAME CHAPTER NAME

KADAM ENVIRONMENTAL CONSULTANTS | JUNE,2019 40

Kadam Environmental Consultants w w w . ka d a m en v i r o . c o m

Envi ronment for Deve lopment